Pills in a bottle/Credit: coffeehuman/Shutterstock.com
The average prices of top-selling drugs used by Medicare enrollees have tripled in cost since coming on the market, a new report from AARP has found. List prices for these drugs have increased by an average of 226%, rising at a considerably higher rate than inflation, and AARP officials said this reflected a general trend in the pharmaceutical industry. The report also points to recently passed legislation that allows Medicare to negotiate drug prices in an effort to moderate rising drug costs for both Medicare enrollees and those in private health plans.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
